Endocrinology
| T1D
Endocrinology
T1D
Racial Differences in Technology Use Among Type 1 Diabetes in a Safety-Net Hospital
book_2
Source:
Endo Online 2020 - Poster session
calendar_today
Published on Medfyle:
July 2020
headphones
4
min
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Key messages
- Racial disparities in use of diabetes technologies including insulin pump and continuous glucose monitoring are present in children with type 1 diabetes; limited data exists in racially diverse, adult populations.
- We examined variation in diabetes technology use in an adult safety-net endocrinology clinic and after adjusting for age, language spoken, insurance, and income found that non-white individuals with type 1 diabetes are less than half as likely to use diabetes technology as white individuals.
- Across all racial and ethnic groups, individuals using sensor augmented pump therapy had the lowest HbA1c.
- Increased attention to equitable allocation of diabetes technologies is required; we hope this research will encourage further examination of disparities in access to treatments for patients with type 1 diabetes and help facilitate development of interventions to increase technology use among minority patients with T1D.
Presenting Author
Read more
arrow_downward
Hide
arrow_upward
Kathryn Fantasia, MD
Boston University School of Medicine,
Boston Medical Center, Boston, MA USA
Dr. Kathryn Fantasia received her medical degree at Albany Medical College. She completed her internal medicine residency at Boston Medical Center. She is currently a third-year endocrinology fellow at Boston Medical Center and is completing a master of science degree in health services and systems research at Boston University School of Public Health.
